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The dynamics of a bacterial population exposed to the minimum inhibitory concentration (MIC) of an antibiotic is an im-
portant issue in pharmacological research. Therefore, a novel antibiotic susceptibility test is urgently needed that can both pre-
cisely determine the MIC and accurately select antibiotic-resistant strains from clinical bacterial populations. For this purpose, 
we developed a method based on Fick’s laws of diffusion using agar plates containing a linear gradient of antibiotic. The gra-
dient plate contained two layers. The bottom layer consisted of 15 mL agar containing the appropriate concentration of en-
rofloxacin and allowed to harden in the form of a wedge with the plate slanted such that the entire bottom was just covered. 
The upper layer consisted of 15 mL plain nutrient agar added with the plate held in the horizontal position. After allowing ver-
tical diffusion of the drug from the bottom agar layer for 12 h, the enrofloxacin concentration was diluted in proportion to the 
ratio of the agar layer thicknesses. The uniform linear concentration gradient was verified by measuring the enrofloxacin con-
centration on the agar surface. When heavy bacterial suspensions were spread on the agar surface and incubated for more than 
12 h, only resistant cells were able to form colonies beyond the boundary of confluent growth of susceptible cells. In this way, 
the true MIC of enrofloxacin was determined. The MICs obtained using this linear gradient plate were consistent with those 
obtained using conventional antibiotic susceptibility tests. Discrete colonies were then spread onto a gradient plate with higher 
antibiotic concentrations; the boundary line increased significantly, and gene mutations conferring resistance were identified. 
This new method enables the rapid identification of resistant strains in the bacterial population. Use of the linear gradient plate 
can easily identify the precise MIC and reveal the dynamic differentiation of bacteria near the MIC. This method allows the 
study of genetic and physiological characteristics of individual strains, and may be useful for early warning of antibiotic re-
sistance that may occur after use of certain antimicrobial agents, and guide clinical treatment. 
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Determining the antibiotic susceptibility of pathogenic bac-
teria is an important function of clinical microbiology la-
boratories. For that reason, the Clinical and Laboratory 
Standard Institute (CLSI) and similar organizations have 
established reference standards for antibiotic susceptibility 
testing (AST) methods and for determining pharmacokinetic 
(PK)/pharmacodynamics (PD) breakpoints and clinical val-
ues. Using a standard testing method, we can determine the 
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minimum inhibitory concentration (MIC) and inhibition 
zone diameter, which indicate whether the pathogen is sen-
sitive or resistant to antibiotics used in clinical practice 
[1–3]. Over the years numerous countries around the world 
have been committed to the standardization of AST and 
surveillance of antibiotic-resistant bacteria [4–7]. However, 
the widespread use of antibiotics has significantly increased 
bacterial resistance [8–10], and the bacterial MIC far ex-
ceeds break point. For that reason, population dynamics of 
bacteria near the MIC is becoming an important question in 
the pharmacology of antibiotics. A novel method to pre-
cisely determine MICs is urgently needed, as well as the 
ability to identify “super” antibiotic-resistant strains in clin-
ical bacterial populations. 
As early as 1952, Szybalski [11] empirically established 
a gradient plate method to isolate antibiotic-resistant bacte-
ria, but the method was used primarily to screen resistant 
strains rather than for AST [12–14]. In this study, we de-
veloped an improved method designed according to Fick’s 
laws of diffusion [11,15]. A uniform linear increase in the 
antibiotic concentration along the gradient axis was verified 
by measuring enrofloxacin concentration on the agar sur-
face. When heavy bacterial suspensions were spread on the 
agar surface and incubated for more than 12 h, the boundary 
between resistant colonies and the confluent growth of sus-
ceptible cells demonstrated the true MIC of enrofloxacin 
and enabled identification of resistant strains. This method 
may be useful for early warning of antibiotic resistance to 
guide the clinical use of antibiotics.  
1  Materials and methods 
1.1  Strain and materials 
Escherichia coli ATCC 25922, enrofloxacin, 1.5% Luria 
Broth (LB) agar medium, 1.5% agar medium, 9-cm petri 
dishes, 5-mL centrifuge tubes, phosphoric acid-triethylamine 
buffer, fluorescence spectrophotometer meter (HITACH 
F4500), 96-well plates. 
1.2  MIC determination of enrofloxacin to ATCC 25922 
by microdilution method 
According to the CLSI standard [3], AST was performed 
with enrofloxacin using three dilution gradients: 1, 0.5, 0.25, 
0.125, 0.062, 0.031, 0.016, and 0.008 g mL1; 0.8, 0.4, 0.2, 
0.1, 0.05, 0.025, 0.0125, and 0.006 g mL1; and 0.6, 0.3, 
0.15, 0.075, 0.038, 0.019, 0.009, and 0.0045 g mL1.  
1.3 Determination of enrofloxacin MIC against E. coli 
ATCC 25922 by agar dilution method 
Enrofloxacin concentration was set as the dilution gradient 
of 1, 0.5, 0.25, 0.125, 0.062, 0.031, 0.016, 0.008 g mL1, 
according to the CLSI standard. For AST, the bacteria were 
spread onto the plate at 108 or 103 CFU, instead of point 
inoculation [3].  
1.4  Enrofloxacin concentration-killing curve (CKC) 
for E. coli ATCC 25922 
LB agar plates were prepared with a linear gradient of 0.01, 
0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05 g mL1 
enrofloxacin. About 1000 bacterial cells were spread evenly 
on each plate and incubated at 37°C for 24 h. The number 
of colonies in each plate was then counted, and the CKC 










   in which N0 is the number of 
bacteria inoculated per plate, N is number of colonies, x is 
the drug concentration, BC50 is the median bactericidal 






   is determined 
by the slope of the curve at BC50 and N0 [16].  
1.5  Determination of enrofloxacin recovery rate in the 
agar 
A standard curve between fluorescence intensity and en-
rofloxacin concentration was constructed. A dilution series 
of 0.1, 0.01, 0.001, 0.0001, 0.00001 g mL1 enrofloxacin 
solution was prepared with phosphoric acid-triethylamine 
buffer (pH 3.0). Fluorescence intensity was detected with a 
F4500 fluorescence spectrophotometer (excitation wave-
length 278 nm, absorption at 446 nm, voltage 600 V) [17].  
A medium containing 1.5% agar and 1, 2, 4, or 8 g 
mL1 enrofloxacin was poured into 9-cm petri dishes (15 
mL/dish). After the agar solidified, 10-mm circular agar 
blocks were removed. Each block was weighed, placed into 
1 mL phosphate-triethylamine buffer (pH 3.0) in a 5-mL 
centrifuge tube, and heated in water bath to dissolve the 
agar, and then cooled. The heating and cooling steps were 
carried out without agitation to allow the agar to settle. The 
supernatant was used to measure fluorescence intensity of 
enrofloxacin, and the concentration of each block was de-
termined using the standard curve.  
1.6  Preparation and verification of a linear gradient 
plate  
Two layers of agar were poured into each of the 24 linear 
gradient plates. A bottom layer consisting of 15 mL LB agar 
(about 55°C) with 2 g mL1 enrofloxacin was allowed to 
harden in the form of a wedge with the plate slanted such 
that the entire bottom was just covered. The tilt direction 
was marked with an arrow. With the plate in the normal hor-
izontal position, another 15 mL plain LB agar was added. 
After allowing vertical diffusion of the drug from the bot-
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tom agar surface for 12 h, the enrofloxacin concentration 
was diluted in proportion to the ratio of the agar layer 
thicknesses. In this way, the enrofloxacin gradually in-
creased from the theoretical concentration of 0 to 2 g mL1 
along the gradient axis (Figure 1A).  
 
 
Figure 1  Gradient plate consisting of two agar layers. 
LB medium with 1.5% agar (15 mL) was poured into 
9-cm petri dishes and solidified. Then 10-mm circular agar 
blocks were removed, weighed, and affixed to the solidified 
linear gradient plate surface equidistant along the tilt axis in 
three rows with seven blocks per row (Figure 1B). The 24 
gradient plates were then incubated at 37°C. Every hour, all 
the blocks on one of the plates were removed, and each 
block was placed into 1 mL phosphoric acid-triethylamine 
buffer (pH 3.0) in a 5-mL centrifuge tube to determine the 
enrofloxacin concentration. 
1.7  Determination of enrofloxacin MIC against E. coli 
ATCC 25922 using the gradient plate  
Overnight cultures of E. coli ATCC 25922 (100 L, 109 
CFU mL1) were spread evenly onto the gradient plate (top 
concentrations of 0.01, 0.02, 0.04, 0.08, and 0.1 g mL1) 
and incubated at 37°C for 12 h. Resistant cells forming col- 
onies beyond the boundary of confluent growth indicated 
the true enrofloxacin MIC against the bacterial population. 
The plate in which the natural boundary appeared in the 
middle was selected. The distance from the lowest concen-
tration point to the boundary along the tilt axis was meas-
ured. MIC was calculated according to the linear gradient 
relationship and antibiotic concentration.  
1.8  Characteristics of the inoculum spread on the gra-
dient plate 
All the discrete colonies (large and small) and some sam-
ples of bacteria from the area of dense confluent growth 
were inoculated into antibiotic-free liquid medium, incu-
bated for 12 h, and then spread onto a higher concentration 
gradient plate. Bacterial growth and colony location were 
then analyzed. In addition, the quinolone resistance-deter-       
mining regions of gyrA, gyrB, and parC, parE were ampli-
fied from the total DNA of each colony, and mutations re-
lated to drug-resistance were analyzed (Table 1) [18]. 
2  Results  
2.1  Determination of enrofloxacin MIC against E. coli 
ATCC 25922 using the microdilution method 
As indicated in Figure 2, the three different gradients of 
double-dilution enrofloxacin produced three different MIC 
results by the microdilution method. The finding 0.025 g 
mL1 was most accurate, but was obtained using an artifi-
cially set gradient. When the tested strain possesses high 
resistance, such artificially set gradient will produce greater 
errors in the estimated MIC. In addition, this method cannot 
differentiate resistant strains from the susceptible strains in 
the bacterial population. 
2.2  Determination of enrofloxacin MIC against E. coli 
ATCC 25922 using the agar dilution method 
This method also uses an artificially set gradient. However, 
the drug-resistant strains can be isolated using the plates 
prepared with specific antibiotic concentrations. As shown 
in Figure 3, the MIC was 0.0625 g mL1 when 1200 CFU  
Table 1  PCR primer sequences for gyrA, gyrB, parC, and parE 
Target genes Primer sequences (5′ to 3′) Primer length (bp) Amplicon length (bp) 
gyrA 
F: TGCCAGATGTCCGAGAT 17 
269 
R: GTATAACGCATTGCCGC 17 
gyrB 
F: GCCTTTCTTCACTTTGTACAGCG 23 
269 
R: GTGACGGCGGTACTCACCTG 20 
parC 
F: TATGCGATGTCTGAAC 16 
264 
R: GCTCAATAGCAGCTCGGAAT 20 
parE 
F: CTGACCGAAAGCTACGTCAACC 22 
264 
R: CGTTCGGCTTGCCTTTCTTG 20 
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Figure 2  Enrofloxacin MICs against E. coli ATCC 25922 were 0.031, 
0.025, 0.038 g mL1 as assessed by the microdilution method. 
 
Figure 3  Enrofloxacin MICs against E. coli ATCC 25922 were 0.0625 
and 0.125 g mL1 as assessed by the agar dilution method. 
inoculum was used, but increased to 0.125 g mL1 with 
108 CFU. The problems associated with the two common 
AST methods recommended by CLSI were discussed in 
detail in our review [19]. 
2.3  Determination of enrofloxacin MIC against E. coli 
ATCC 25922 using the CKC method  
The bactericidal effect according to enrofloxacin concentra-
tion was fully described by the CKC (Figure 4), with 
BC50=0.0205 g mL1 and BC1=0.0364 g mL1. Fitting the 
data eliminated the error introduced by the artificial gradient. 
However, the gradient was stepwise, not linear. Discrete 
colonies were obtained only between BC1 and BC50. We can 
rule out the emergence of mutant colonies, because inocu-
lums were less than 1000 CFU to facilitate colony counting 
[17]. 
2.4  Determination and verification of linear enrofloxa-
cin concentration on the gradient plate surface 
The standard curve of enrofloxacin concentration and fluo-
rescence intensity, y=52666x+306.2, showed a strong linear 
correlation (R2=0.998). The recovery rate of enrofloxacin 
from agar blocks was 99%, indicating that the agar (1.5%,  
w/v) did not absorb significant amounts of enrofloxacin.  
The time-concentration curves in Figure 5 show that en-
rofloxacin concentrations in different regions of the gradient 
plate surface increased rapidly over time. The higher en-
rofloxacin concentration in the bottom agar layer diffused 
more rapidly. After 12 h, the enrofloxacin concentration at 
each point stabilized, and concentration-distance curves 
could be fitted with a linear equation (Figure 6). In this way, 
the drug concentration at any point on the agar surface 
along the gradient could be accurately determined. 
2.5  Determination of enrofloxacin MIC against E. coli 
ATCC 25922 using the gradient plate  
In the gradient plate prepared with 0.03125 g mL1 en-
rofloxacin (bottom agar layer), two distinct regions were 
observed: an area of continuous dense growth and an area of 
discrete colonies (Figure 7A). The boundary concentration 
was MIC=0.018 g mL1. The gradient plate thus displayed 
continuous changes of the population regarding colony 
formation and regional distribution under increasing drug 
concentrations. This technique is a simple and intuitive 
method to visualize the CKC. Furthermore, it can identify  
 
 
Figure 4  Enrofloxacin CKC against E. coli ATCC 25922 using the CFU 
counting method. 
 
Figure 5  Enrofloxacin concentrations at different times in various loca-
tions along the gradient. The legend indicates the distance between the test  
point and the point of highest concentration. 
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Figure 6  Enrofloxacin concentrations in various locations at different 
times fitted to linear equations. 
 
resistant strains in the bacterial population for further ge-
netic and physiologic analysis. 
With increasing inoculum amounts, the number of dis-
crete large colonies increased, but the location of the MIC 
line was unaltered (data not shown). 
2.6  Characteristics of the inoculum spread on the gra-
dient plate 
Bacteria from three different locations of the continuous 
growth area were sampled, and three discrete large colonies 
and three discrete small colonies (Figure 7A) were also se-
lected for analysis. These samples were inoculated sepa-
rately into liquid LB medium, incubated for 8 h, and then 
spread onto new gradient plates with different antibiotic 
concentrations. 
Figure 7B shows that when bacteria from the continuous 
dense area were spread onto the same concentration gradi-
ent plate, the distribution of the colonies was consistent with 
that of Figure 7A, indicating that the characteristics of the 
susceptible bacteria were not influenced by the drug. Re-
sistant strains in the original population, which were inhib-
ited by the more numerous susceptible cells in the areas of 
continuous dense growth, formed large discrete colonies in 
the areas of higher antibiotic concentration. 
Bacteria from the small colonies were then spread onto 
gradient plates prepared with 0.125 g mL1 enrofloxacin. 
The colony distribution pattern was also consistent with 
Figure 7A, but the boundary concentration was four times 
higher (Figure 7C). Spreading the large discrete colonies on 
plates prepared with 0.125 g mL1 enrofloxacin produced a 
similar pattern; however, the boundary concentration was 
16 times higher (Figure 7D).  
None of the colonies analyzed showed gene mutations in 
gyrB, parC, or parE. However, mutations were found in 
amino acid 87 of gyrA: GGC→TAC, glycine→tyrosine 
(small discrete colonies); GGC→TAC, glycine→tyrosine 
(two large discrete colonies); and GGC→GAC, glycine→ 
 
Figure 7  A, Area of smooth continuous dense growth and small colonies, 
and area of large discrete colonies of E. coli ATCC 25922 on the gradient 
plate prepared with 0.03125 g mL1 enrofloxacin. Arrows show colonies 
chosen for further analysis. B, Distribution of colonies after spreading 
bacteria from different locations of the continuous dense growth shown in 
Figure 7A onto a gradient plate prepared with 0.03125 g mL1 enrofloxa-
cin. C, Distribution of colonies after spreading bacteria from three small 
discrete colonies shown in Figure 7A onto a gradient plate prepared with 
0.125 g mL1 enrofloxacin. D, Distribution of colonies after spreading 
bacteria from three large discrete colonies shown in Figure 7A onto a gra- 
dient plate prepared with 0.5 g mL1 enrofloxacin. 
aspartic acid (one large discrete colony). 
3  Discussion 
Problems with current AST methods and standards pro-
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posed by CLSI were previously discussed [19]. The disk 
diffusion method recommended by the World Health Or-
ganization is easy and has been widely used for nearly 40 
years [2–4]. The E-test and spiral gradient endpoint method 
have been used for more than 20 years, but are still expen-
sive because the technology is protected by patent [20,21]. 
In both methods, the drug diffuses into the agar plate in a 
three-dimensional hemispherical manner. The non-linear 
gradient diffusion and different physical and chemical 
properties of drug molecules are difficult to fit with a uni-
versal model [22–26]. The antibiotic concentration at the 
edge of the inhibition zone cannot be used to determine 
MIC, and using the diameter is also a poor indicator of 
MIC; therefore, MIC is rarely reported using these meth-
ods. The Kirby-Bauer method was established to deter-
mine the linear relationship between the inhibition zone 
diameter and MIC. However, there is not a one-to-one 
correspondence; when testing a large number of strains, 
one inhibition zone diameter may correspond to more than 
one MIC, and vice versa.  
Because testing conditions (e.g., drug disk size drug 
dosage, bacterial inoculum, agar concentration, incubation 
time, and temperature) affect formation of the inhibition 
zone, improvement of the agar dilution method has been 
discussed for many years [27–32]. 
It is difficult to produce a continuous linear gradient us-
ing the agar dilution method; the measured concentration is 
a range of concentrations. The same problem exists when 
determining the mutation prevention concentration (MPC) 
for single-step mutants [33]. The CKC method was pro-
posed to describe dynamic changes in bacterial populations 
exposed to linear concentration increases of a drug. The 
CKC from BC99 to BC1 can be used to calculate the BC50 
and other parameters [17,34,35]. The differential analysis 
method is based on turbidity to exclude the interference of 
resting cells in the bacterial population. This technique can 
be combined with a two-dimensional contour map to show 
the effects of drug concentration and time [36]. Both meth-
ods can provide important information for PK/PD analysis 
[37,38].  
These conventional methods have the same problem in 
that they cannot directly determine the precise MIC, but 
produce mixed populations or colonies at the concentration 
near the MIC. It is impossible to isolate strains that are re-
sistant to concentrations just above the MIC. However, use 
of linear gradient agar plates solves these difficulties.  
Fick’s laws of diffusion characterize the one-dimensional 
diffusion of small molecules in a homogeneous liquid phase. 









  in which D is the dif-
fusion coefficient, C is the solute concentration, x is diffu-
sion displacement, and t is diffusion time [15,39]. The drug 
concentration at all points in the bottom agar layer C is the 
same before the upper agar layer is added. After the upper 
layer is poured, the molecules diffuse in the direction per-







 decreases rapidly, approaching zero as t approaches 





 is greater than 0, thus a 
continuous linear gradient forms in the direction perpendic-
ular to the slope of the bottom agar layer. Because the upper 
agar surface intersects with the surface of the bottom agar 
layer, the concentration on the upper surface forms a linear 
gradient. This is the theoretical principle of the gradient 
plate.  
In this paper, LB agar plates containing linear gradients 
of enrofloxacin were prepared. The diffusion equilibrium 
was approached at 12 h, and the stable linear gradient was 
verified. When a large amount of bacteria was grown on the 
gradient plates, two types of colonies were observed in two 
different areas of the plate, thereby allowing the accurate 
determination of enrofloxacin MIC. Two types of mutant 
strains were isolated from the discrete colonies.  
The linear gradient plate method provides significant 
advantages and shows potential for use in antibiotic re-
sistance research and clinical AST.  
(i) Accurate determination of the MIC. The bacterial 
population naturally forms two regions on the gradient plate. 
The boundary between the two regions provides an accurate 
assessment of the MIC. This method is superior to the arti-
ficial dilution series in tubes or the agar dilution method, 
particularly when evaluating high-resistant strains. The lin-
ear gradient plate and CKC methods are different ap-
proaches that provide equally satisfactory estimates of the 
bactericidal effect and resistance of the population exposed 
to a continuous linear gradient of enrofloxacin. The BC50 
(0.0205 g mL1) and boundary concentration (0.018 g 
mL1) were very close and were equivalent to the smallest 
MIC (0.025 g mL1) of the microdilution assay. However, 
of the three results, the concentration at the natural bounda-
ry (0.018 g mL1) is a more accurate MIC of the dominant 
population. For example, when the bacterial inoculum in-
creased (Figure 3), the inhibitory concentration appeared to 
increase, as assessed by the number of colonies in the agar 
dilution method. We were unable to determine the CKC 
(Figure 4) since the bacterial growth was dense, and the 
colonies too small to count. In contrast, the linear gradient 
plate reveals the precise MIC of dominant population sta-
bly.  
(ii) Analysis of bacterial resistance. The heterogeneity of 
drug sensitivity displayed when the bacterial population 
increased reflects the emergence of strains with different 
resistance mutations and phenotypes. These discrete colo-
nies from the region of high antibiotic concentration were 
spread on a new gradient plate, and a new MIC was ob-
tained (the MPC). The mechanisms of resistance revealed 
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the diversity of strains in the population, and resistance 
phenotypes were not limited to one-step mutations. The 
gradient plate method thus provides a new method for stud-
ying bacterial resistance phenotypes. 
(iii) Early warning of drug-resistant strains may be used 
to determine clinical treatment. The gradient plate method 
can quickly identify consecutive drug-resistant strains. This 
method can be used to study the increase of resistant phe-
notypes, mutation rates, biochemical mechanisms of re-
sistance mechanisms, and their molecular regulation.  
(iv) The linear gradient plate can show individual bacte-
ria changes of colony proliferation, reveal growth inhibition 
and death according to drug concentration and time, and 
evaluate time dependence or concentration dependence of 
the drug.  
Based on differential equations and the contour map, we 
have proposed a new method to characterize the combined 
roles of drug concentration and treatment time. This method 
is suitable for laboratory studies to determine the mecha-
nism of action and for PK/PD analysis [36]. The linear gra-
dient plate method is simple and feasible for use in a typical 
clinical laboratory. The combination of the two methods 
enables a more comprehensive understanding of interactions 
between drugs and bacterial populations. However, its uni-
versality, availability, and potential clinical applications 
require further testing and improvement. 
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